Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jordan Pritikin

Plastic Surgery within the Head & Neck Chicago, IL Medical Doctor

NPI 1770585259 CMS profile 352596

111 W Washington St, Suite 903, Chicago, IL 60602

Open in the dashboard

General payments

$167,132

635 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$174,487 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Jordan Pritikin of Chicago, IL is reported in the CMS Open Payments database as having received $167,132 across 635 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $174,487 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Plastic Surgery within the Head & Neck profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,901 76
2024 General $35,925 104
2023 General $27,447 105
2022 General $29,416 114
2021 General $24,949 84
2020 General $19,294 66
2019 General $23,199 86

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jordan Pritikin
  • Plastic Surgery within the Head & Neck median
  • Middle half of Plastic Surgery within the Head & Neck
  • National median

In program year 2025, general payments to Jordan Pritikin were reported at $6,901. Among 399 Plastic Surgery within the Head & Neck profiles paid that year, the median was $237 and the middle half received between $103 and $520.

Show as a table
Year Jordan Pritikin Plastic Surgery within the Head & Neck median Middle half National median
2019 $23,199 $200 $82–$550 $163
2020 $19,294 $120 $46–$330 $114
2021 $24,949 $166 $60–$382 $132
2022 $29,416 $208 $83–$530 $149
2023 $27,447 $202 $77–$538 $160
2024 $35,925 $260 $99–$645 $164
2025 $6,901 $237 $103–$520 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Aerin Medical Inc. $109,547 181 payments
  2. OptiNose US, Inc. $42,056 143 payments
  3. Olympus America Inc. $5,622 19 payments
  4. Genzyme Corporation $1,912 77 payments
  5. Regeneron Healthcare Solutions, Inc. $1,755 51 payments
  6. ALK-Abello, Inc $1,266 59 payments
  7. Intersect ENT, Inc. $950 11 payments
  8. GlaxoSmithKline, LLC. $773 38 payments
  9. Gyrus ACMI, Inc. $690 1 payment
  10. Spirair, Inc. $465 2 payments
  11. Other $2,096 53 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $86,805 57 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $35,550 34 payments
  3. Food and Beverage $18,474 500 payments
  4. Honoraria $17,635 14 payments
  5. Travel and Lodging $8,495 28 payments
  6. Education $173 2 payments
Products named General payments · program years 2019–2025
  1. VIVAER STYLUS $76,808 107 payments
  2. Xhance $42,056 143 payments
  3. RHINAER STYLUS $36,473 55 payments
  4. VivAer $14,581 11 payments
  5. RhinAer $14,581 11 payments
  6. Vivaer RF Stylus $14,577 28 payments
  7. DIEGO POWER DISSECTOR HANDPIECE,TRIGGER SWITCH ENABLED $4,295 10 payments
  8. DUPIXENT Immunology $2,007 79 payments
  9. DUPIXENT Inflammation And Immunology $1,316 38 payments
  10. Odactra $1,086 52 payments
  11. Other $9,714 250 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

97

Median for Otolaryngology: 297

Drug cost

$86,823

Median for Otolaryngology: $6,314

Branded share of claims

21.6%

Median for Otolaryngology: 10.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Dupixent Pen Dupilumab Brand 21 $84,209
Ipratropium Bromide Generic 59 $2,490
Doxycycline Hyclate Generic 17 $124

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 9,296 Part D prescribers listed as Otolaryngology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 29 billing codes

Paid by Medicare

$47,025

Medicare's payments for the services billed

Medicare patients

166

Average age 74

Services billed

587

82 women, 84 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 58%
Arthritis 46%
Ischemic heart disease 28%
Diabetes 16%
Chronic kidney disease 16%
Osteoporosis 16%
Heart failure 14%
Atrial fibrillation 13%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 7 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Xhance
$13,961 — —
DUPIXENT
$755 21 —
NUCALA
$108 — —
Odactra
$31 — —
Grastek
$31 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 7 in the dashboard with a free account

Records

635 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery within the Head & Neck in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record